Diffuse Large B-cell Lymphoma Classification Tied Up Nicely with a “String”

Por Rimsza, Lisa M.
Publicado no Clin Cancer Res (2015)

Lack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma

Por Schmelz, Monika, Montes-Moreno, Santiago, Piris, Miguel, Wilkinson, Sarah T., Rimsza, Lisa M.
Publicado em 2012

A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma

Por Rimsza, Lisa M., Unger, Joseph M., Tome, Margaret E., LeBlanc, Michael L.
Publicado em 2011

Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma

Por Cycon, Kelly A, Mulvaney, Kathleen, Rimsza, Lisa M, Persky, Daniel, Murphy, Shawn P
Publicado em 2013

Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes

Por Pastos, Karen M., Slayton, William B., Rimsza, Lisa M., Young, Linda, Sola-Visner, Martha C.
Publicado em 2006

Differences between Newborn and Adult Mice in Their Response to Immune Thrombocytopenia

Por Hu, Zhongbo, Slayton, William B., Rimsza, Lisa M., Bailey, Matthew, Sallmon, Hannes, Sola-Visner, Martha C.
Publicado em 2010

A Phase 2 Study of Vorinostat for Treatment of Relapsed or Refractory Hodgkin Lymphoma: SWOG S0517

Por Kirschbaum, Mark H., Goldman, Bryan H., Zain, Jasmine M., Cook, James R., Rimsza, Lisa M., Forman, Stephen J., Fisher, Richard I.
Publicado em 2011

Copper Chelator ATN-224 Induces Peroxynitrite-Dependent Cell Death in Hematological Malignancies

Por Lee, Kristy, Briehl, Margaret M., Mazar, Andrew P., Batinic-Haberle, Ines, Reboucas, Julio S., Glinsmann-Gibson, Betty, Rimsza, Lisa M., Tome, Margaret E.
Publicado em 2013

CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class I...

Por Rimsza, Lisa M., Chan, Wing C., Gascoyne, Randy D., Campo, Elias, Jaffe, Elaine S., Staudt, Louis M., Delabie, Jan, Rosenwald, Andreas, Murphy, Shawn P.
Publicado em 2009

A Phase II Trial of Single Agent Bevacizumab in Patients with Relapsed, Aggressive Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0108

Por Stopeck, Alison T., Unger, Joseph, Rimsza, Lisa M., Bellamy, William T., Iannone, Maria, Persky, Daniel O., LeBlanc, Michael, Fisher, Richard I., Miller, Thomas P.
Publicado em 2009

Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas

Por Rimsza, Lisa M, Day, William A, McGinn, Sarah, Pedata, Anne, Natkunam, Yasodha, Warnke, Roger, Cook, James R, Marafioti, Teresa, Grogan, Thomas M
Publicado no Diagn Pathol (2014)

Synergistic Induction of Apoptosis in High-Risk DLBCL by BCL2 Inhibition with ABT-199 Combined With Pharmacologic Loss of MCL1

Por Li, Lingxiao, Pongtornpipat, Praechompoo, Tiutan, Timothy, Kendrick, Samantha L., Park, Soyoung, Persky, Daniel O., Rimsza, Lisa M., Puvvada, Soham D., Schatz, Jonathan H.
Publicado no Leukemia (2015)

A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell...

Por Stopeck, Alison T., Unger, Joseph M., Rimsza, Lisa M., LeBlanc, Michael, Farnsworth, Brent, Iannone, Maria, Glenn, Martha J., Fisher, Richard I., Miller, Thomas P.
Publicado em 2012

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

Por Tome, Margaret E., Johnson, David B. F., Rimsza, Lisa M., Roberts, Robin A., Grogan, Thomas M., Miller, Thomas P., Oberley, Larry W., Briehl, Margaret M.
Publicado em 2005

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

Por Wilkinson, Sarah T., Vanpatten, Kristie A., Fernandez, Diane R., Brunhoeber, Patrick, Garsha, Karl E., Glinsmann-Gibson, Betty J., Grogan, Thomas M., Teruya-Feldstein, Julie, Rimsza, Lisa M.
Publicado em 2012

A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitors

Por Tula-Sanchez, Ana A, Havas, Aaron P, Alonge, Peter J, Klein, Mary E, Doctor, Samantha R, Pinkston, William, Glinsmann-Gibson, Betty J, Rimsza, Lisa M, Smith, Catharine L
Publicado em 2013

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemother...

Por Persky, Daniel O., Dornan, David, Goldman, Bryan H., Braziel, Rita M., Fisher, Richard I., LeBlanc, Michael, Maloney, David G., Press, Oliver W., Miller, Thomas P., Rimsza, Lisa M.
Publicado em 2012

Reply to “Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story?” Haematologica. 2012;97(11):e45

Por Persky, Daniel O., Dornan, David, Goldman, Bryan H., Braziel, Rita M., Fisher, Richard I., LeBlanc, Michael, Maloney, David G., Press, Oliver W., Miller, Thomas P., Rimsza, Lisa M.
Publicado em 2012

Decreased MHC class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of CIITA promoters III and IV

Por WILKINSON, SARAH T., FERNANDEZ, DIANE R., MURPHY, SHAWN P., BRAZIEL, RITA M., CAMPO, ELIAS, CHAN, WING C., DELABIE, JAN, GASCOYNE, RANDY D., JAFFE, ELAINE S., ROSENWALD, ANDREAS, STAUDT, LOUIS M., RIMSZA, LISA M.
Publicado em 2009

Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma

Por Stasik, Christopher J., Nitta, Hiroaki, Zhang, Wenjun, Mosher, Charles H., Cook, James R., Tubbs, Raymond R., Unger, Joseph M., Brooks, Tracy A., Persky, Daniel O., Wilkinson, Sarah T., Grogan, Thomas M., Rimsza, Lisa M.
Publicado em 2010